Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACOR > SEC Filings for ACOR > Form 8-K on 4-Jun-2013All Recent SEC Filings

Show all filings for ACORDA THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro



Change in Directors or Principal Officers, Submission of Matters to a Vot

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(e) On May 31, 2013, the Board of Directors of Acorda Therapeutics, Inc. (the "Company") increased Enrique Carrazana, M.D.'s 2013 annual base salary from $390,600 to $420,000. This salary adjustment was approved by the Board based on an analysis of base salaries of comparable executives at peer companies. The Board determined that an adjustment was needed to set Dr. Carrazana's base salary in a range that is competitive.

Item 5.07 Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting of Stockholders on May 30, 2013 (the "Annual Meeting") at the Residence Inn By Marriott, 7 Executive Boulevard, Yonkers, NY 10701. 36,765,920 shares of the Company's common stock, or 90.67% of the shares of the Company's common stock issued and outstanding on the record date for the Annual Meeting, were present in person or represented by proxy at the Annual Meeting. Summarized below are descriptions of the proposals voted on at the Annual Meeting and the final results of such voting:

Proposal One: Election of directors

As described in the Company's 2013 Proxy Statement, the Company's Board of Directors nominated three individuals to serve as Class II directors for a term to expire on the date of the Company's 2016 Annual Meeting of Stockholders or until their successors are duly elected and qualified. All of such nominees were elected by a plurality vote (and also received a majority vote, for purposes of the majority vote provisions of the Company's Bylaws), as follows:

Director Votes For Votes Withheld Broker Non-Votes Peder K. Jensen, M.D. 30,576,375 4,190,227 1,999,318 John P. Kelley 30,549,755 4,216,847 1,999,318 Sandra Panem, Ph.D. 33,806,652 959,950 1,999,318

Proposal Two: Ratification of appointment of independent auditors

The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2013, by the following vote:

Votes For Votes Against Abstentions
36,598,741 157,433 9,746

Proposal Three: Advisory (non-binding) vote to approve named executive officer compensation

The Company's stockholders voted, in an advisory, non-binding manner, to approve the compensation of the Company's Named Executive Officers as disclosed in the Company's 2013 Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the executive compensation tables and the related footnotes and narrative accompanying the tables (the "say-on-pay vote"). The Company's stockholders voted as follows to approve such executive compensation pursuant to the say-on-pay vote:

Votes For Votes Against Abstentions Broker Non-Votes 22,816,424 11,943,625 6,553 1,999,318

  Add ACOR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACOR - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.